scholarly article | Q13442814 |
P356 | DOI | 10.1159/000100579 |
P8608 | Fatcat ID | release_qlevokgq6zbgvoxdqeemlmh3vu |
P698 | PubMed publication ID | 17356292 |
P50 | author | Peter E. Clayton | Q38318622 |
P2093 | author name string | Price DA | |
Meyer S | |||
Hall CM | |||
Patel L | |||
Isaac H | |||
Cusick C | |||
P2860 | cites work | Hyperleptinaemia is associated with impaired gonadotrophin response to GnRH during late puberty in obese girls, not boys | Q38335228 |
Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-month depot (11.25 mg). | Q44126974 | ||
Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty | Q44723013 | ||
Gonadotropin-suppressive therapy in girls with early and fast puberty affects the pace of puberty but not total pubertal growth or final height | Q47186654 | ||
Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty: final height, body proportions, body composition, bone mineral density, and reproductive function | Q47251143 | ||
Body mass index as a measure of adiposity among children and adolescents: A validation study | Q57314382 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 157-163 | |
P577 | publication date | 2007-03-13 | |
P1433 | published in | Hormone Research | Q5903788 |
P1476 | title | Efficacy of a monthly compared to 3-monthly depot GnRH analogue (goserelin) in the treatment of children with central precocious puberty | |
P478 | volume | 68 |
Q42905662 | A case of mental retardation with paraphilia treated with depot leuprorelin. |
Q58914848 | Central precocious puberty: treatment with triptorelin 11.25 mg |
Q38115615 | Current pharmacotherapy of central precocious puberty by GnRH analogs: certainties and uncertainties |
Q47552080 | Effects of Huang Bai (Phellodendri Cortex) on bone growth and pubertal development in adolescent female rats |
Q90453490 | Long-term effects and significant Adverse Drug Reactions (ADRs) associated with the use of Gonadotropin-Releasing Hormone analogs (GnRHa) for central precocious puberty: a brief review of literature |
Search more.